Objective: In people living with HIV (PLHIV), we sought to test the hypothesis that long term anti-retroviral therapy restores the normal T cell repertoire, and investigate the functional relationship of residual repertoire abnormalities to persistent immune system dysregulation. Methods: We conducted a case-control study in PLHIV and HIV-negative volunteers, of circulating T cell receptor repertoires and whole blood transcriptomes by RNA sequencing, complemented by metadata from routinely collected health care records. Results: T cell receptor sequencing revealed persistent abnormalities in the clonal T cell repertoire of PLHIV, characterized by reduced repertoire diversity and oligoclonal T cell expansion correlated with elevated CD8 T cell counts. We found no evidence that these expansions were driven by cytomegalovirus or another common antigen. Increased frequency of long CDR3 sequences and reduced frequency of public sequences among the expanded clones implicated abnormal thymic selection as a contributing factor. These abnormalities in the repertoire correlated with systems level evidence of persistent T cell activation in genome-wide blood transcriptomes. Conclusions: The diversity of T cell receptor repertoires in PLHIV on long term anti-retroviral therapy remains significantly depleted, and skewed by idiosyncratic clones, partly attributable to altered thymic output and associated with T cell mediated chronic immune activation. Further investigation of thymic function and the antigenic drivers of T cell clonal selection in PLHIV are critical to efforts to fully re-establish normal immune function.
Objective: In people living with HIV (PLHIV), we sought to test the hypothesis that long term anti-retroviral therapy restores the normal T cell repertoire, and investigate the functional relationship of residual repertoire abnormalities to persistent immune system dysregulation. Methods: We conducted a case-control study in PLHIV and HIV-negative volunteers, of circulating T cell receptor repertoires and whole blood transcriptomes by RNA sequencing, complemented by metadata from routinely collected health care records. Results: T cell receptor sequencing revealed persistent abnormalities in the clonal T cell repertoire of PLHIV, characterized by reduced repertoire diversity and oligoclonal T cell expansion correlated with elevated CD8 T cell counts. We found no evidence that these expansions were driven by cytomegalovirus or another common antigen. Increased frequency of long CDR3 sequences and reduced frequency of public sequences among the expanded clones implicated abnormal thymic selection as a contributing factor. These abnormalities in the repertoire correlated with systems level evidence of persistent T cell activation in genome-wide blood transcriptomes. Conclusions: The diversity of T cell receptor repertoires in PLHIV on long term anti-retroviral therapy remains significantly depleted, and skewed by idiosyncratic clones, partly attributable to altered thymic output and associated with T cell mediated chronic immune activation. Further investigation of thymic function and the antigenic drivers of T cell clonal selection in PLHIV are critical to efforts to fully re-establish normal immune function.
Keywords:
T cell activation; T cell repertoire; antiretroviral therapy; blood transcriptome; chronic inflammation; human immunodeficiency virus; people living with HIV
Authors: M Connors; J A Kovacs; S Krevat; J C Gea-Banacloche; M C Sneller; M Flanigan; J A Metcalf; R E Walker; J Falloon; M Baseler; I Feuerstein; H Masur; H C Lane Journal: Nat Med Date: 1997-05 Impact factor: 53.440
Authors: A Kök; L Hocqueloux; H Hocini; M Carrière; L Lefrou; A Guguin; P Tisserand; H Bonnabau; V Avettand-Fenoel; T Prazuck; S Katsahian; P Gaulard; R Thiébaut; Y Lévy; S Hüe Journal: Mucosal Immunol Date: 2014-07-02 Impact factor: 7.313
Authors: David M Naeger; Jeffrey N Martin; Elizabeth Sinclair; Peter W Hunt; David R Bangsberg; Frederick Hecht; Priscilla Hsue; Joseph M McCune; Steven G Deeks Journal: PLoS One Date: 2010-01-29 Impact factor: 3.240
Authors: Jason M Brenchley; David A Price; Timothy W Schacker; Tedi E Asher; Guido Silvestri; Srinivas Rao; Zachary Kazzaz; Ethan Bornstein; Olivier Lambotte; Daniel Altmann; Bruce R Blazar; Benigno Rodriguez; Leia Teixeira-Johnson; Alan Landay; Jeffrey N Martin; Frederick M Hecht; Louis J Picker; Michael M Lederman; Steven G Deeks; Daniel C Douek Journal: Nat Med Date: 2006-11-19 Impact factor: 53.440
Authors: Nicholas A Watkins; Arief Gusnanto; Bernard de Bono; Subhajyoti De; Diego Miranda-Saavedra; Debbie L Hardie; Will G J Angenent; Antony P Attwood; Peter D Ellis; Wendy Erber; Nicola S Foad; Stephen F Garner; Clare M Isacke; Jennifer Jolley; Kerstin Koch; Iain C Macaulay; Sarah L Morley; Augusto Rendon; Kate M Rice; Niall Taylor; Daphne C Thijssen-Timmer; Marloes R Tijssen; C Ellen van der Schoot; Lorenz Wernisch; Thilo Winzer; Frank Dudbridge; Christopher D Buckley; Cordelia F Langford; Sarah Teichmann; Berthold Göttgens; Willem H Ouwehand Journal: Blood Date: 2009-02-19 Impact factor: 22.113
Authors: Andrea M H Towlerton; Shashidhar Ravishankar; David G Coffey; Camille E Puronen; Edus H Warren Journal: Front Immunol Date: 2022-05-02 Impact factor: 8.786
Authors: Aneesh Chandran; Joshua Rosenheim; Gayathri Nageswaran; Leo Swadling; Gabriele Pollara; Rishi K Gupta; Alice R Burton; José Afonso Guerra-Assunção; Annemarie Woolston; Tahel Ronel; Corinna Pade; Joseph M Gibbons; Blanca Sanz-Magallon Duque De Estrada; Marc Robert de Massy; Matthew Whelan; Amanda Semper; Tim Brooks; Daniel M Altmann; Rosemary J Boyton; Áine McKnight; Gabriella Captur; Charlotte Manisty; Thomas Alexander Treibel; James C Moon; Gillian S Tomlinson; Mala K Maini; Benjamin M Chain; Mahdad Noursadeghi Journal: Cell Rep Med Date: 2022-03-04
Authors: Jennifer Beecker; Curtis Cooper; Mark G Kirchhof; Anton L Pozniak; Juergen K Rockstroh; Kim A Papp; Jan P Dutz; Melinda J Gooderham; Robert Gniadecki; Chih-Ho Hong; Charles W Lynde; Catherine Maari; Yves Poulin; Ronald B Vender; Sharon L Walmsley Journal: Dermatol Ther (Heidelb) Date: 2022-04-21
Authors: Eliza Gil; Cristina Venturini; David Stirling; Carolin Turner; Liku B Tezera; Giuseppe Ercoli; Tina Baker; Katharine Best; Jeremy S Brown; Mahdad Noursadeghi Journal: Front Immunol Date: 2022-07-28 Impact factor: 8.786